血纤维蛋白

用人工血纤维蛋白平板检测其活性。

The activity was measured by use of artificial fibrin plate .

纤维蛋白溶解酶是溶解血纤维蛋白凝块的药物。

Fibrinolytic enzymes are agents that dissolve fibrin clots .

巴曲酶组和联合治疗组血纤维蛋白原明显低于ASA组（P〈0.01）；

Batroxobin group and combined group was significantly lower than fibrinogen ASA group ( P0.01 ) .

目的：探讨冠心病（CoronaryHeartDisease，CHD）患者血纤维蛋白原（Fg）和尿酸（UA）水平变化及其与冠心病病变程度的关系。

Objective : To explore the relationship between change of plasma fibrinogen ( Fg ) and uric acid ( UA ) level in patients with coronary heart disease .

对两组患者的年龄、性别、血脂水平、血纤维蛋白原水平、血糖水平、发热、白细胞增多、平均动脉压、糖尿病史和CT早期梗死征象进行比较。

Their ages , sexes , the levels of lipid , fibrinogen and blood glucose , fever , leukocytosis , mean arterial pressure , diabetes history and signs of early cerebral infarction on CT were compared .

Western印迹显示该单克隆抗体能特异地与纤溶因子结合，与其它蛋白无交叉反应，此外，这2株单克隆抗体具有抑制纤溶因子溶解人血纤维蛋白的作用。

Western blot indicated that the two clones could bind specifically to the fibrinolytic factor , and no cross reaction with other venom proteins was observed . Also , they could inhibit the fibrinolytic action of the fibrinolytic factor .

最近发现SPC促进细胞的移动，诱导成纤维细胞表达与细胞移动有关的血纤维蛋白溶酶原激活剂。

Recently , a lot of studies have been demonstrated that SPC increased cell migration and induced the expression of plasminogen activator related to cell migration .

结果：①DM组较NDM组血纤维蛋白原、空腹血糖、甘油三酯浓度高（P均0.05）；而高密度脂蛋白胆固醇DM组较NDM组低（P0.05）。

Results : ① Serum fibrinogen , blood glucose and serum lipid concentration in DM group was markedly higher than that of NDM group ( P0.05 ) .

复发性脑梗死的可控危险因素主要是高血压病，血纤维蛋白原、TC水平、血浆粘度和全血高切还原粘度升高及HDL-C降低；

The major controllable risk factors to recurrent cerebral infarction are hypertension , the increased value of blood fibrinogen , TC , plasma and whole blood viscosity and decreased HDL-C.

PAI-1是纤溶系统活性的生理性抑制剂，有研究认为，它的大量分泌，可以使血纤维蛋白清除障碍而发生肺纤维化。

Plasminogen activity inhibitor-1 ( PAI-1 ) , a major inhibitor of fibrinolysis system , has been implicated in disordered alveolar fibrin clearance and subsequent pulmonary fibrosis .

人血纤维蛋白溶酶原K5环的基因合成、表达、纯化与活性鉴定

Gene Synthesis , Expression and Purification of Human Plasminogen Kringle 5 in E.coli and Its Antiangiogenesis Activity

方法：采用Giemsa染色和MTT检测法，经过电镜扫描，分段对比观察，研究3T3细胞在血纤维蛋白凝块上的生长情况。

METHOD : Growth of the cells on blood fibrin clot was studied by phase-contrast , scanning and transmission electron microscopy and by Giemsa stain and MTT assay .

巴曲酶组及联合治疗组血纤维蛋白原水平、血高切应力均降低（P0.005，P0.01）。

Plasma fibrinogen levers and high sheer rate decreased significantly in Batroxobin group and ASA combined with Batroxobin group compared with ASA group ( P0.05 , P0.01 ) .

结论：血纤维蛋白原、C-反应蛋白、PMN是慢性炎症的独立敏感指标，与冠心病心功能不全有一定关系并对缺血性心功能不全病情及预后的预测有一定的价值。

Conclusion : The parameters of inflammation such as Fg , CRP and PMN , may be closely related with coronary heart disease , and can predict the prognosis of IHF .

它不仅能有效地延长凝血酶对人血纤维蛋白原聚集的凝血酶时间而且能抑制人凝血酶对特异性三肽发色底物（CBZPheValArgPNA）的催化水解。

Thrombin inhibitor S-254 could not only prolong the thrombin time efficiently but also inhibit the human thrombin activity of hydrolyzing specific tripeptide chromogenic substrate ( CBZ-Phe-Val-Arg-PNA ) .

目的观察依那普利对急性心肌梗死（AMI）患者组织型血纤维蛋白溶酶原激活物（tPA）、血纤维蛋白溶酶原激活物抑制物（PAI）及血管紧张素Ⅱ（AⅡ）水平变化。

Objective To investigate the changes of plasma tissue plasminogen activator ( t PA ), plasminogen activator inhibitor ( PAI ) and angiotensin ⅱ ( A ⅱ) level in patients with acute myocardial infarction ( AMI ) treated by enalapril .

统计学分析未提示肝功能Child-pugh分级、血小板计数、凝血酶原时间、血纤维蛋白原含量及饮酒比例等是肝硬化PVT形成的危险因素（P>005）。

However , no significant statistic differences were found in the etiology of cirrhosis , Child-pugh classification of liver function , blood platelet counting ( BPC ), prothrombin time ( PT ), and plasma fibrinogen level between the study and control groups ( P > 0 05 ) .

治疗组血纤维蛋白原水平降低显著，不良反应轻微。

The serum fibrinogen level was decreased significantly in the treatment group .

二是水解血纤维蛋白或纤溶酶原；新氯化-水解法的原理和应用

Principle and application of the new chlorination - hydrolization process

一种来自海洋细菌的血纤维蛋白溶酶的分离纯化及性质研究

Purification and property of a plasmin from a marine bacteria

培养细胞分泌的血纤维蛋白溶酶原激活物的研究

Studies on plasminogen activators secreted by various cultured cells

一种产血纤维蛋白溶酶菌株的筛选及液体发酵条件的选择

Selection of Ferment Medium for the secretion of plasmin from a marine bacteria

人血纤维蛋白胶保存条件的研究

Research of preservation condition of human blood fibrin glue

不稳定型心绞痛危险分层中血纤维蛋白原浓度的临床意义

Clinical significance of serum fibrinogen levels in risk classification of unstable angina pectoris

免疫复合物共振散射光谱法测定人血纤维蛋白原

A Simple and Sensitive Immune Resonance Scattering Spectral Assay for Determination of Fibrinogen

血浆中存在的一种球蛋白；在血液凝结时转化成血纤维蛋白。

A globulin present in blood plasma ; converts to fibrin when blood clots .

异体血纤维蛋白粘合剂临床疗效的研究

Research of fibrin glue in clinical therapy

血纤维蛋白原浓度与高密度脂蛋白胆固醇浓度呈负相关。

There was negative correlation between the plasma concentration of Fg and high-density lipoprotein cholesterol .

血纤维蛋白溶解酶是一类能直接降解血纤维蛋白的酶，在体外其主要来源于微生物、蚯蚓、蛇毒、某些海洋无脊椎动物和海藻等。

The fibrinolytic enzyme that directly hydrolysis fibrin mainly originate from earthworm , snake venom and microorganism .

溶解血纤维蛋白并除去小的血液凝块的正常过程。

A normal ongoing process that dissolves fibrin and results in the removal of small blood clots .